title: [Purging with rituximab in vivo combined with autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma: clinical analysis of 26 cases].
authors.affiliation: Peking University Cancer Hospital & Institute, Department of Lymphoma, Key Laboratory of Carcinogenesis & Translational Research Ministry of Education, Beijing 100142, China.
authors.forename: Chen
authors.initials: C
authors.lastname: Zhang
authors.forename: Xiao-pei
authors.initials: XP
authors.lastname: Wang
authors.forename: Zhi-tao
authors.initials: ZT
authors.lastname: Ying
authors.forename: Ling-yan
authors.initials: LY
authors.lastname: Ping
authors.forename: Wen
authors.initials: W
authors.lastname: Zheng
authors.forename: Yan
authors.initials: Y
authors.lastname: Xie
authors.forename: Ning-jing
authors.initials: NJ
authors.lastname: Lin
authors.forename: Wei-ping
authors.initials: WP
authors.lastname: Liu
authors.forename: Li-juan
authors.initials: LJ
authors.lastname: Deng
authors.forename: Yu-qin
authors.initials: YQ
authors.lastname: Song
authors.forename: Jun
authors.initials: J
authors.lastname: Zhu
mesh_terms: D000293:Adolescent; D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D016465:Bone Marrow Purging; D005260:Female; D006801:Humans; D016393:Lymphoma, B-Cell / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation; D012189:Retrospective Studies; D000069283:Rituximab; D014182:Transplantation, Autologous; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab